Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial (September 2017) Doi: Lisdexamfetamine Dimesylate (Vyvanse), A Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (May 2010) Doi: The Influence of Depressive Symptoms on Executive Functioning in Binge Eating Disorder: A Comparison of Patients and Non-Obese Healthy Controls (April 2019) Doi: Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review (August 05, 2021) Doi: SSRI Antidepressant Medications: Adverse Effects and Tolerability (February 01, 2001) Doi: Treatment of Obese Patients With Binge Eating Disorder Using Topiramate: A Review (July 07, 2009) Doi: Successful Treatment of Binge Eating Disorder With the GLP-1 Agonist Semaglutide: A Retrospective Cohort Study (August 08, 2023) Doi:
You may need to obtain prior authorization first, though, depending on your medical history
Your provider can determine whether an FDA-approved alternative (such as tretinoin for skin remodeling or minoxidil for hair loss) might be partially covered by your MAPD plan
Ipamorelin is a selective growth hormone-releasing peptide that stimulates the pituitary gland to release growth hormone in a natural pulsatile pattern
If hypersensitivity reactions occur, discontinue use of Wegovy , treat promptly per standard of care, and monitor until signs and symptoms resolve
BPC-157 works through multiple complementary mechanisms: increasing blood vessel formation, reducing inflammation, enhancing collagen production, and amplifying growth hormone signaling